Fennec Pharmaceuticals
Price & Volume
Stats
See more52W Range | $5.65-$10.45 |
Market Cap | $348.4M |
Shares Short | 623,377 |
Financials
See moreRevenue (12 Mos) | $50.9M |
Revenue Growth (YoY) | 72.6% |
Gross Profit (12 Mos) | $47M |
Diluted EPS | -$0.29 |
News
See moreYahoo Finance • 7 days ago
Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter
Yahoo Finance • 9 days ago
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
Yahoo Finance • 16 days ago
Adherex Technologies Q1 Earnings Call Highlights
Yahoo Finance • 17 days ago
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
About
CEO | Mr. Jeffrey S. Hackman |
Address | 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 35 |